Broad-Spectrum Antibiotic for Wound Infection
For acute wound infections in adults without drug allergies, initiate empiric therapy with amoxicillin-clavulanate 875/125 mg twice daily orally for mild-moderate infections, or vancomycin plus piperacillin-tazobactam intravenously for severe infections with systemic signs. 1
Severity Assessment and Initial Approach
The choice of antibiotic depends critically on infection severity and clinical presentation:
- Assess for systemic inflammatory response syndrome (SIRS): Look for temperature >38°C or <36°C, tachypnea >24 breaths/minute, tachycardia >90 beats/minute, or white blood cell count >12,000 or <4,000 cells/μL 1
- Obtain wound cultures before initiating antibiotics to guide subsequent de-escalation 2
- Perform Gram stain if available to direct initial therapy 3
Empiric Antibiotic Selection by Severity
Mild-Moderate Infections (Outpatient or Non-Severe)
Amoxicillin-clavulanate 875/125 mg twice daily orally is the first-line broad-spectrum option 1:
- Covers both aerobic and anaerobic bacteria including Staphylococcus aureus (methicillin-susceptible) and streptococci 1
- Note: Some gram-negative rods may be resistant, and it misses MRSA 1
Alternative oral regimens if amoxicillin-clavulanate is unsuitable 1:
- Cephalexin 500 mg four times daily (covers MSSA but misses anaerobes)
- Clindamycin 300-400 mg four times daily (excellent for gram-positives and anaerobes, but misses many gram-negatives)
Severe Infections (Hospitalized, SIRS Present, or Necrotizing Features)
Vancomycin plus piperacillin-tazobactam is the recommended broad-spectrum regimen 1:
- Vancomycin: 30 mg/kg/day in 2 divided doses IV (covers MRSA and resistant gram-positives) 1
- Piperacillin-tazobactam: 3.37 g every 6-8 hours IV (covers gram-negatives and anaerobes) 1
Alternative broad-spectrum IV regimens for severe infections 1:
- Vancomycin plus ampicillin-sulbactam 1.5-3.0 g every 6 hours IV
- Vancomycin plus a carbapenem (imipenem-cilastatin 1 g every 6-8 hours, meropenem 1 g every 8 hours, or ertapenem 1 g daily)
Special Considerations
Bite Wounds (Animal or Human)
Amoxicillin-clavulanate 875/125 mg twice daily remains first-line for both animal and human bites 1:
- Covers Pasteurella multocida (animal bites) and Eikenella species (human bites) 1
- If hospitalized: ampicillin-sulbactam 1.5-3.0 g every 6 hours IV 1
Suspected Gas Gangrene or Necrotizing Infection
Urgent surgical exploration is mandatory 1:
- Empiric therapy: vancomycin plus piperacillin-tazobactam, ampicillin-sulbactam, or carbapenem 1
- If clostridial myonecrosis confirmed: switch to penicillin 2-4 million units every 4-6 hours IV plus clindamycin 600-900 mg every 8 hours IV 1
Critical Pitfalls to Avoid
Overuse of broad gram-negative coverage: Studies show 80% of hospitalized wound infection patients receive unnecessarily broad gram-negative coverage or prolonged courses >10 days 4. Most simple wound infections are caused by gram-positive organisms (S. aureus, streptococci) and do not require extended gram-negative coverage 1, 4.
Duration of therapy: Limit treatment to 7-10 days for most wound infections 1. Prolonged courses increase antimicrobial resistance risk without improving outcomes 4.
MRSA considerations: Add specific MRSA coverage (vancomycin, linezolid, or daptomycin) only if 1:
- Patient has failed initial therapy
- Markedly impaired host defenses present
- SIRS with hypotension
- Known MRSA colonization or local high prevalence
De-escalation Strategy
Narrow antibiotic spectrum within 2-4 days based on culture results and clinical response 2:
- If cultures grow MSSA only: switch to nafcillin, oxacillin, or cefazolin 1
- If cultures grow streptococci only: switch to penicillin 1
- Discontinue gram-negative coverage if cultures negative for these organisms 4
Environmental factors affect antibiotic efficacy: Purulent exudate, fibrinous material, and pH changes at the wound site can reduce antibiotic activity, emphasizing the importance of adequate wound debridement alongside antimicrobial therapy 3.